PST (Pulse Signal Therapy) Osteoporosis

PST (Pulse Signal Therapy) Osteoporosis


PST Osteoporosis treatment was homologated by CE in 13. 11.2003 and became available commercially in April 2004.

Bone and cartilage are types of connective tissue, with similar features. Several studies published on the last years show that chondrocytes (cartilage cells) and osteoblasts (bone formation cells) arise from connective tissues and transcriptional regulator Cbfa1 is crucial for bone and cartilage formation.

Both bone and cartilage respond positively to mechanic pressure, liquid flow (with transfer of electric charges), pulsed electromagnetic field system and other similar types of external stimulus. This is why, factures with a difficult consolidation have been treated successfully with PST since 1996.

The positive effects of PST, on bone formation have been observed on Osteoporosis Clinical Studies. These results have been showing significant increase of trabecular bone density (internal bone layer) in patients using PST, comparing with the control group.

The percentage of trabecular bone gain is higher than cortical bone (external bone layer).

In osteoporosis, the decline of initial bone mineral density is analyzed through trabecular bone. The return of this bone is showed by a very well defined micro –architecture, which is essential to strength and stability.

The electromagnetic field transmitted by PST Osteo treatment is different from the Ortho system.  For this reason there are different activation cards, for distinct programmes.


Clinical Indication

Primary osteoporosis (Type 1)


This type of osteoporosis affects mainly women aged between 50 and 70 years old. It is related with the lack of the female hormone –estrogen – this hormonal alteration happens after menopause. The balance between bone structure and bone remodeling is disrupted by hormonal alteration, resulting in bone frailty and loss of bone density.

The damages are initially evident in the cancellous bone structure; therefore it is more susceptible to fracture:


Forearm (cubitus and radius)


Neck of Femur


The relation between lack of sexual hormones and this type of osteoporosis is well known, so the measures to prevent fractures are:

 -A balanced diet rich in calcium

 - Physical exercise and skeletal exercise to stimulate osteoblasts activity

- Medication according with doctor guidance


 Primary Osteoporosis (Type 2)


Both men and women aged more than 70 years old are susceptible to this type of osteoporosis. Besides affecting cancelous bone it also affects cortical bone.

Leading to fratures in the long bones:


-        Femoral diaphysis

-        Forearm (cubitus and radius)

The main causes for osteoporosis type II are:


-        Bone ageing (or senile osteoporosis)

-        Lack of calcium or  vitamin D

-        Lack of physical exercise


Despite the fact that bone ageing is a normal and unavoidable process, calcium and vitamin D deficits can be restored. This can be achieved by adopting a balanced diet and a healthy lifestyle  that includes physical exercise, specially walking.


Secondary Osteoporosis


Both men and women are likely to suffer from this type of osteoporosis which may occur associated to another illness. Only 5 % of all cases of osteoporosis correspond to this.


Secondary Osteoporosis is related with the following diseases:


-        Hyperadrenalism (with excessive corticoids production)

-        Long term use of corticosteroids

-        Gastrointestinal system diseases 

-        Hyperthyroidism

-        Bedridden patients for long periods

-        Excess use of alcohol, tobacco and coffee


The consequences are the same as in primary osteoporosis, in particular the occurrence of fractures

Approximately 20% of all osteoporosis cases are associated to another disease - secondary osteoporosis . The other 80% of cases are primary osteoporosis associated with post menopause and senile Osteoporosis.


Some patients might feel a slight tingling or heat during treatment. The patient might also feel pain alterations, but is a temporary effect and it is considered a positive reaction towards PST.



Non invasive and drug-free.  It is a simple treatment and usually well tolerated by the patients, despite of  age or physical condition.


Pain free

 The treatment itself is painless. Some discomfort may only occur due to the position required during treatment. It is required that the patient remains lying down for the treatment which can cause discomfortmainly with cervical, spine or pelvis therapy. If this is the case the medical doctor may prescribe some painkillers.


Side effects

There haven’t been any reports of side effects associated with this treatment to date.



Short term outcomes

Clinical trials show an improvement of bone density 3 months after completion of treatment. This is measured using DXA scanning.

A recent study in Munich demonstrated a 10% improvement of bone density throughout 6 months post treatment. This study involved 100 female patients aged 55-77.


No age restrictions

There are no restrictions to this treatment regarding age or physical ability.


The treatment may be combined with other types of rehabilitation according with the doctor’s prescription.

 Improving Life’s quality

In general the treatment will improve patient’s quality of life by increasing bone density and reducing the risk of bone fractures.